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INFLUENCE OF COMBINED BYSTANDER AND ADAPTIVE RESPONSE
EFFECTS ON RADON CASE-CONTROL STUDIES - A MICRODOSE ANALYSIS
Bobby E. Leonard  International Academy of Hi-Tech Services, Inc.
Richard E. Thompson  Department of Biostatistics, Bloomberg School of Public
Health, Johns Hopkins Medical Center
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 Since the publication of the BEIR VI (1999) report on health risks from radon, a sig-
nificant amount of new data has been published showing various mechanisms that may
affect the ultimate assessment of radon as a carcinogen, in particular the potentially dele-
terious Bystander Effect (BE) and the potentially beneficial Adaptive Response radio-pro-
tection (AR). The case-control radon lung cancer risk data of the pooled 13 European
countries radon study (Darby et al 2005, 2006) and the 8 North American pooled study
(Krewski et al 2005, 2006) have been evaluated. The large variation in the odds ratios of
lung cancer from radon risk is reconciled, based on the large variation in geological and
ecological conditions and variation in the degree of adaptive response radio-protection
against the bystander effect induced lung damage. The analysis clearly shows Bystander
Effect radon lung cancer induction and Adaptive Response reduction in lung cancer in
some geographical regions. It is estimated that for radon levels up to about 400 Bq m-3
there is about a 30% probability that no human lung cancer risk from radon will be expe-
rienced and a 20% probability that the risk is below the zero-radon, endogenic sponta-
neous or perhaps even genetically inheritable lung cancer risk rate. The BEIR VI (1999)
and EPA (2003) estimates of human lung cancer deaths from radon are most likely sig-
nificantly excessive. The assumption of linearity of risk, by the Linear No-Threshold
Model, with increasing radon exposure is invalid.
Keywords: Radon Case-Control Studies, Non-Linearity Adaptive Response Bystander Effects
1. INTRODUCTION
1.1 Microdose Analysis of Case-Control Studies
Radon lung cancer studies have been performed using the case-con-
trol method of data collection and analysis. BEIR VI (1999) provides lung
cancer risk data from some of the early case-control studies in their
Figure 3-2. These studies involve the matching of each human lung can-
cer case with one or more non-cancer cohorts with similar demographic
characteristics. In these studies, both cases and controls are matched with
Address correspondence to Bobby E. Leonard, International Academy of Hi-Tech
Services. Inc., P.O. Box 5004, Severna Park, Maryland 21146; Phone: 443/223-6082; Fax:
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exposures to similar levels of low Radon concentrations. Such studies have
been performed in Europe (13 studies) and North America (8 studies)
with these data recently being pooled by several analysis groups to provide
more statistical power (Darby et al 2005, 2006, Krewski et al 2005, 2006).
The pooling of data from these studies is based on the assumption that
between-site differences seen in the observed relationship between lung
cancer risk and radon exposure are due to random measurement variabil-
ity and the true relationship is independent of site locality and only
dependent on the carcinogenic sensitivity of human lung tissue to alpha
radiation, which both Darby et al (2005, 2006) assumed to be Linear No-
Threshold (LNT) compatible with BEIR VI (1999). BEIR VI (1999) sum-
marized their justification of LNT for human lung cancer risk as follows:
“The choice was to use a linear relationship between risk and low doses of
radon progeny without a threshold. The choice was based primarily on con-
siderations related to the stochastic nature of the energy deposition by
alpha particles; at low doses, a decrease in dose simply results in a decrease
in the number of cells subjected to the same insult. That observation, com-
bined with the evidence that a single alpha particle can cause substantial
permanent damage to a cell and that most cancers are of monoclonal ori-
gin, provides the mechanistic basis of the use of a linear model at low doses.
In addition, as discussed in the report, exposure-response relationships esti-
mated from the observational data in miners with low exposures, and from
the case-control studies of indoor radon, are consistent with linearity.”
Of considerable significance is the very recent case-control lung can-
cer epidemiological study of Thompson et al (2008), for Worcester
County, Massachusetts (making now a total of 9 North America studies),
showing a significant reduction of lung cancer incidence with increasing
residential Radon concentrations. Since the BEIR VI (1999) was issued, a
large amount of new research data has been published about low level
radiation dose response, primarily sponsored by the United States
Department of Energy Low Radiation Dose Research Program. We here
report Part III of a three part study of the combined influence from the
deleterious behavior of the Bystander Effect (BE) and from the radio-pro-
tective behavior of Adaptive Response (AR), on the human health risks
from radon. In the separate Part I of this study (Leonard et al 2010a), we
have shown that cellular dose response from radon progeny and other
similar high LET alpha particles, in the absence of any low LET radiation
inducing AR, can be typified by a representative alpha particle dose
response shape and accurately characterized by a modified microdose
BaD Bystander Model (with some minor modifications given in Part I)
first proposed by Brenner et al (2001). It is shown, for radon concentra-
tions at human domestic and workplace levels, as provided by the BEIR
VI (1999) report, that the carcinogen causing cellular chromosome dam-
age in the human lung must be from Bystander Damage to neighboring
B. E. Leonard and others
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cells adjacent to directly hit cells. This is based on the latest evaluation of
the human lung cells alpha particle “hit” (traversal) rate per Bq m-3 of
radon exposure provided by James et al (2004). The Bystander Damage
dose response, from broad-beam and micro-beam in vitro data, is shown
to be non-monotonic concave downward in shape for human domestic
level, low radon exposures. Only at the higher radon levels received by
the underground miners would the dose response be from cellular/alpha
particle Direct Damage and linear or linear-quadratic as provided by
many other published alpha dose response data. This representative dose
response shape is provided in Part I as Figure 10 (Leonard et al 2010a)
and the explicit shapes in the low radon residential bystander region is
given in Figure 16B. It is concluded that the dose response for lung can-
cer risks from radon should not be expected to be Linear No-Threshold,
contrary to Figure 3-2 of BEIR VI (1999) (see the bottom panel of Figure
1, Part I), and contrary to the pooled linear fits to the European and
North American case-control data analysis shown in Figure 2 of Part I
(Leonard et al 2010a) and provided herein as Figure 1. The basic evi-
dence presented in Part I, from in vitro data, is that the Bystander Effect
from radon and progeny alpha particles is dominant in inducing lung
cancer in humans from radon at residential levels.
Conversely in the separate Part II (Leonard et al 2010b), we exam-
ined the potential influence of combined deleterious Bystander Effects
and Adaptive Response radio-protection by assuming, based also on a
very large amount of in vitro BE and AR data, that AR is operable for low
LET ionizing radiations that humans routinely receive from natural back-
ground and man-made radiations. Significant to the Part II study of
potential Adaptive Response effects on the human lung cancer risks from
radon is the fact that single low LET radiation induced charged particle
tracks through sensitive regions of cells induces an AR protection of 40 to
70 % against chromosome damage. This has been evidenced after the
Poisson threshold transition region of AR dose response data such as that
of Azzam et al (1996) and Redpath et al (2001, 2003) [see Figures 2A and
2B of Leonard (2007a)]. Further, Sawant et al (2001) and Zhou et al
(2003) have shown that low LET X-ray priming doses can reduce the
transformation frequency rate and level of chromosome aberrations from
alpha particle exposures (see Figures 3A and 3B of Part II) . The adaptive
response protection is found to be independent of the type of radiations,
from 28 keV mammogram X-rays to 232 Mev cosmic ray protons, and
independent of cell species for five different cell species although the
level of protection and the dose range of the protection does vary some-
what dependent on the specific energy deposition of the single low LET
charged particle traversals [see Figure 9 of Leonard (2008b]. In examin-
ing whether Adaptive Response may induce radio-protection against the
alpha particle induced human lung damage, we used the United Nations
Radon Case-Controls - Adaptive Response and Bystander Effects
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FIGURE 1. Linear fits of individual studies in two pooled case-control radon studies. Panel A - Radon
relative risks for 13 pooled European case-control studies. From Darby et al (2005, 2006) with per-
mission. Panel B – Radon relative risks for 8 pooled North American case-control studies. From
Krewski et al (2005, 2006) with permission. 
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Scientific Committee on the Effects of Atomic Radiations (UNSCEAR
2000) estimated human exposures to ionizing radiations as the AR induc-
ing radiation sources. It was found, at the world-wide mean radiation lev-
els, that about 30% of the human lung cells should experience AR radio-
protection and at the high UNSCEAR (2000) levels 100% of human lung
cells should receive AR protection. From Parts I (Leonard et al 2010a)
and II (Leonard et al 2010b), we show that the human lung cancer risk
dose response should be non-linear from alpha particle cell damage and
further, different ecological and geographical environments world-wide
should impose a large range Adaptive Response radio-protection and a
wide range of observed odds ratios of lung cancer risk as is indeed
observed in the European (13 studies) and North American (8 studies)
case-control studies as seen in Figure 1. This is supportive of the non-lin-
ear premises of Morgan (2006). Based on these premises, in this Part III,
we examine the odds ratio data for these 21 pooled studies, the very
recent Massachusetts study of Thompson et al (2008) and the China study
of Blot et al (1990) for non-linear lung cancer risks as expected from the
results of Parts I and II.
2. MATERIALS AND METHODS
2.1 Method - Recent Case-Control Studies May Provide Insight Into the
Variation of Bystander Damage and Adaptive Response Radio-Protection
From Human Lung Cancer
We provide as Figure 1 the reproduction of the graphs of data and
their linearized fits for the Darby et al (2005, 2006) pooled 13 European
case-control and the Krewski et al (2005, 2006) pooled 8 North American
case-control studies. It was most likely a large disappointment for the par-
ticipants in the pooled studies to find such a very large variation in the
Odds Ratio Relative Lung Cancer Risks as a function of increasing radon
concentration for the different geographical localities. In the Results
Section herein, we analyze these 21 data sets plus the Shengyang, China
(Blot et al 1990) study and the very recent Massachusetts (MA)
(Thompson et al 2008) study. We first examine the validity of the assump-
tion of linearity that was assumed to produce Figure 1, where a very wide
range in linearized slopes is observed for both the Krewski etal (2005,
2006) and Darby et al (2005, 2006) pooled data with some showing neg-
ative lung cancer risks with increasing radon levels. Due to this wide
range, we then divided the data into two groups, i.e. positive sloped (high
risk group) and negative sloped (low risk group) sets, and performed sin-
gle linear fits. Because our Part I and II analysis concludes that radon
lung cancer risks should not be expected to be Linear No-Threshold, we
next considered, without imposing explicitly any adaptive response crite-
ria, that there may be more than the Linear No-Threshold mechanisms
Radon Case-Controls - Adaptive Response and Bystander Effects
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affecting the dose responses. The well known Papworth Poisson
Validation Test (Papworth 1975, Savage and Papworth 2000) was applied
and revealed that a single linear mechanism premise to be invalid, show-
ing over-dispersion of the data for a hypothesis of a single linear cancer
risk mechanism. To examine a hypothesis, premised from the Part I and
II results, that BE and AR influence should produce non-linear human
lung cancer risk behavior, both the Darby et al (2005, 2006) plus China
(Blot et al 1990) and the Krewski et al (2005, 2006) plus MA (Thpmpson
et al 2008) data low risk group and the high risk group sets were each trial
fit to 3rd, 4th and 5th degree polynomials. With the suspect that they may
reflect minimal radon induced lung cancer response, the three lowest
risk data sets of the Krewski et al (2005, 2006) plus Massachusetts (MA)
data sets, i.e. the Massachusetts (MA). New Jersey (NJ) and Missouri (MO-
IIa) data in Table 1, were then individually fit to the basic Microdose
Model for adaptive response protection (Leonard 2007a), given as
Equation (3) of Part II, i.e. neglecting any bystander lung damage, with
excellent success. These three lung cancer risk sets thus show a net AR
B. E. Leonard and others
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TABLE 1. Adjusted Odds Ratios (SE) and Corresponding 95% Confidence Interval as a Function
of Radon Exposure Categories for the Eight North American Sites Study (Krewski et al 2005, 2006)
and the Thompson et al (2008) MA Study. Values in Brackets are 95%CLs. 
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protection against lung cancer with increasing radon levels which signifi-
cantly reflects also a reduction in naturally occurring, spontaneous lung
cancers from non-radon causes by being below the zero radon cancer
incident rates.
In the Analysis and Discussion Sections, we discuss the validity of in
vitro data to predict in vivo human dose response and provide recent in
vivo data of live mammalian examples of adaptive response protection.
3. RESULTS
3.1 Linear Analysis of Krewski et al (2005, 2006) and Darby et al (2005,
2006) Case-Control Data
Table 1 provides the numerical values for the odds ratios of lung can-
cer risks for the radon concentrations reported by Krewski et al (2005,
2006) and MA (Thompson et al 2008) studies. At the request of the Darby
et al (2005, 2006) group, we only provide their graphical presentation in
Figure 1A but used their numerical data in our analysis herein. What is
very apparent, from the Figure 1A from Darby et al (2005, 2006) and
Figure 1B from Krewski et al (2005, 2006), is that there is a very large vari-
ation in the linearized odds ratios slopes in lung cancer risks from the
respective 13 different European and 9 different geographical locations
in North America. In particular, the behavior of the 2 data sets, from New
Jersey – NJ (Schoenberg et al 1990, 1992) and Missouri – MO-IIa
(Alavanja et al 1994, 1999), show very clearly a strongly non-conforming
negative behavior. The odds ratios in the Thompson et al (2008) MA data
shown in their Figure 2 compliments the NJ and MO-IIa negative risk
results for radon exposure values below about 200 Bq m-3. The extreme
differences suggests that more than one dose response mechanism may
be present in the induction, and other cases of lack of induction, of radon
induced lung cancer in humans, contrary to BEIR VI (1999) and Krewski
et al (2005, 2006) and Darby (2005, 2006) premises.
First it is appropriate to more carefully assess the likelihood that the
9 North America lung cancer risk data in Table 1 represent a linear can-
cer induction mechanism as premised by the Linear No-Threshold
hypothesis and shown in Figure 3-2 of BEIR VI (1999) and the bottom
panel of Figure 1, Part I. The BEIR VI (1999) lung cancer Relative Risk is
given by Equation (1), Section 3 of BEIR VI (1999) i.e.
Relative Risk (RR) = 1 + βw (1)
where w is the radon exposure and β estimates the increment in excess
relative risk (ERR) for unit change in exposure. For their Figure 3-2, a
value of about β = 0.0019 per Bq m-3 is used. Table 1 provides the odds
Radon Case-Controls - Adaptive Response and Bystander Effects
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ratio, standard error and 95%CL data values reported from Krewski et al
(2005, 2006) and the values from Thompson et al (2008). As Figure 2A,
we show our linearized best fit, obtained using the Method of Maximum
Likelihood Estimation (Savage and Papworth 2000), for each of the 8
Krewski et al (2005, 2006) North American case-control studies and the
B. E. Leonard and others
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FIGURE 2. Linear best fit of Krewski (Krewski et al 2005, 2006) plus MA (Thompson et al 2008) and
Darby (Darby et al 2005, 2006) plus China (Blot et al 1990) data. Panel A - Use of the Method of
Maximum Likelihood (MLE) to obtain a linear best fit to each of the eight North American lung can-
cer case-control studies pooled by Krewski et al (2005, 2006) and the Thompson et al (2008) case-
control study for Worcester County, Massachusetts. Panel B – Use of MML to fit the high risk pooled
group, i.e. CT, IA, UT-ID, MO-I, MO-IIg and Winn, to linear best fit. Panel C – Use of MML to fit the
low risk North American pooled group (Krewski et al 2005, 2006) i.e. NJ, MA and MO-IIa to linear
best fit. Panel D – The MML linear best fit of each data set of the Darby et al (2005, 2006) and China
(Blot et al 1990) 14 data sets. Panel E - Use of MML to fit the Darby (Darby et al 2005, 2006) high
risk pooled group, to a linear best fit. Panel F - Use of MML to fit the low risk Darby (Darby et al 2005,
2006) and China (Blot et all 1990) pooled group i.e. United Kingdom, Spain, Western Germany and
China to linear best fit. 
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new MA data of Thompson et al (2008) i.e. the data in Table 1. We see an
extreme variation in the linear slopes for the individual sets when
premised by the Linear No-Threshold (LNT) hypothesis. We obtained a
range of values of β’s from -0.0043 per Bq m-3 for NJ to +0.0049 per Bq m-
3 for Iowa (IA). It does not seem plausible, if the data indeed reflects the
lung cancer incidence rate from radon, that there would be negative risk
with increasing radon concentration, if indeed world-wide the true lung
cancer risk is given by a single value of β. We have next separated the
Krewski et al (2005. 2006) data sets into two groups, one group including
all the positive sloped, high risk data sets i.e. CT, IA, M)-I, MO-IIg, UT-ID
and Winn. The second low risk group includes the three negative
responding sets i.e. the MA, MO-IIa and the NJ sets. We have pooled each
group and provide the high risk group linear fit as Figure 2B and the lin-
ear fit for the low risk group as Figure 2C.
The Darby et al (2005, 2006) pooled data have also been examined in
the same way. As Figure 2D, we provide the linearized fit to each of the 13
European data sets and the China data set. Again we find a very large range
for the Excess Relative Risk slopes. We again divided the Darby et al (2005,
2006) data into a positive sloped, high risk group (Austria, France, Czech
Republic, Eastern Germany, Sweden Nationwide, Sweden never-smokers,
Sweden Stockholm, Southern Finland and Italy). The low risk group, con-
taining the negative responding and negligible risk results of Spain, United
Kingdom, Western Germany, Finland Nationwide and China. As Figures 2E
and 2F, we show the pooled linear fits to these two groups.
3.2 Statistical Considerations Relative to the Excessive Odds Ratios – 
A Poisson Fit Test
We have cited in the Introduction section the BEIR VI (1999) sum-
mary statement premising linearity of lung cancer risks from radon. Both
the Krewski et al (2005, 2006) and the Darby et al (2005, 2006) studies are
premised that “The pooling of data from these studies is based on the
assumption that between-site differences seen in the observed relation-
ship between lung cancer risk and radon exposure are due to random
measurement variability and the true relationship is independent of site
locality and only dependent on the carcinogenic sensitivity of human
lung tissue to alpha radiation.” These two pooled studies encompass a
very large amount of case-control data. The following are the case and
control data values for the noted case/control studies; Krewski et al
(2005, 2006) 4081 and 5281 persons, Darby et al (2005, 2006) 7148 and
14208 persons, Thompson et al (2008) 209 and 397 persons, Shenyang,
China (Blot et al 1990) 308 and 356 persons comprising a total of 11746
cases and 20242 controls. Analysis of the net population and of the two
separate groups i.e. North America including MA data and the European
Radon Case-Controls - Adaptive Response and Bystander Effects
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plus China data for linearity should provide a reasonable estimate of the
“true” linear slope constant, β, in Equation (1) for human lung cancer
risk versus radon exposure concentration. Thus for each radon concen-
tration data point, the deviation from the linearized risk curve should be
from “radom measurement variability” (thus Poisson distribution) and,
due to the large populations in the studies, the linearized risk curve
should represent the “true relationship (which) is independent of site
locality”. Thus, a “universal” lung cancer risk. if it exists? The fits clearly
show a very large variation in the lung cancer incidence rates from the
various geographical locations in North America, Europe and China. Our
evaluation, from odds ratio studies shown in Figure 2, is that a statistical-
ly significant difference in the slopes between the sites with a positive
Excess Odds Ratios (EOR) and the sites with negative EOR provides evi-
dence to reject, as a null hypothesis, the premise that the EOR’s obtained
from all the sites estimate one underlying single linear association
between lung cancer risk and radon concentrations. We statistically eval-
uate the hypothesis.
Papworth (1975) was one of the first to observe that, if experimental
data represented a physical process containing a mean value, then the dis-
tribution of data about the mean value should be Poisson distributed
about this mean value if the data variations are related to only random
variations in data collection and assessment i.e. in the case here, radon
data taking processes in obtaining the case-control values. A Poisson
Validation Test is standard procedure in evaluating the validity of chro-
mosome assay data in radiation biology. The Cytogenetic Analysis for radi-
ation dose assessment applies the Poisson Validation Test in the data
analysis related to human overexposures in accident situations (IAEA
2001). For each dose data point on the dose response calibration, thou-
sands of cells are scored for chromosome aberration frequency at each
calibration dose data point. The distribution of these scored values about
the mean value are tested for Poisson conformity. If the variance to mean
ratio is large the data are considered to be over-dispersed. Figure 3A illus-
trates the distribution behavior about the data points on a cytogenetic
dose response calibration curve, reproduced from Figure 3 of Szluinska
et al (2005). For the Excessive Odds Ratio Lung Cancer Risk data, if the
cancer risk rate is indeed linear and independent of any other mecha-
nisms other than Linear No-Threshold dose response for radon human
lung cancer risks, then the best fit slope predicted by each radon con-
centration dose point on the dose response curve should be an assess-
ment of the true linear curve. So for each case-control data point in each
data set i.e. Spain, United Kingdom, France, etc. an experimental esti-
mated value for the true slope is provided by the relation
B. E. Leonard and others
424
10
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 3, Art. 13
https://scholarworks.umass.edu/dose_response/vol10/iss3/13
Radon Case-Controls - Adaptive Response and Bystander Effects
425
FIGURE 3. Statistical evaluation of the case-control data sets for validity of the data. Panel A –
Schematic illustration of the data distribution about individual data points in a chromosome aberra-
tion dose response curve, where each data point is a result of scoring a large number of cells, exposed
to the same dose, for aberrations to obtain a statistical Mean Value for that dose point. The aberra-
tion distribution from the scoring is tested [Papworth (1975) Poisson Validation Test] for validity by
fitting to a Poisson Distribution about the Mean Value. Panel B – The frequency distribution of the
slopes of the Krewski et al (2005, 2006) plus MA (Thompson et al 2008) data and fit to a Normal
Distribution, showing the very large variation about the Mean Value of 0.00085 per Bq m-3. Panel C
– The frequency distribution of the slopes of the Darby et al (2005, 2006) plus China (Blot et al 1990)
data and fit to a Normal Distribution with a Mean Value of 0.00063 per Bq m-3. Panel D – The fre-
quency distributions of the slopes of all the individual data from all the 23 case-control studies
encompassing 109 data points of Odds Ratio Lung Cancer Relative Risks. The Mean Value is 0.00079
per Bq m-3. 
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βexp = Experimental Excess Odds Ratio/Mean Radon Concentration (w)
(2)
Then pooling the case-control data sets should provide a number
of independent Slope Estimates. If Lung Cancer Risk is indeed inde-
pendent of geographical location, as must have been premised by the
participants in the two pooled studies, then the experimental βexp val-
ues must form a Poisson distribution about the true linear slope value
for human lung cancer risk from radon. We have used the computer
“U-Test for Poisson” program of the Poisson Test system “CTAMPOISS”
from the United Kingdom Health Protection Agency (HPA 2008). We
show the results in Figures 3B and 3C. We have graphically examined
the frequency distribution of the Slope Estimate data points given by
Equation (2). Figure 3B provides the distribution of the Equation (2)
slope values for all the Krewski (2005, 2006) plus the Thompson et al
(2008) MA data. The mean value of the slopes is 0.00085 per Bq m-3 of
radon with a very large standard error (SE) of 0.00616. This is a lower
slope than the 0.0011 per Bq m-3 value obtained by Krewski et al (2005,
2006) but we have included the Thompson et al (2008) MA negatively
responding data. Similarly, shown in Figure 3C, we performed the
same analysis for the Darby et al (2005, 2006) plus China (Blot et al
1990) data, again obtaining a lower slope value equal to 0.00063 per Bq
m-3 slope value due to the China data, with a large SE of 0.00629, com-
pared to 0.0011 for the Darby et al (2005, 2006) data. The CTAMPOISS
Poisson Validation Test concludes that both the Krewski et al (2005,
2006) and Darby et al (2005, 2006) slope data set distributions are over-
dispersed and were, on a technical basis, statistically rejected as being
from a single mechanism and “contaminated” from outlier influence.
We performed a similar test of the entire pooled data of Krewski et al
(2005, 2006), Darby et al (2005, 2006), MA (Thompson et al 2008) and
China (Blot et al 1990). This is presented as Figure 3D showing a Mean
Value of 0.00079 per Bq m-3 with a large SE of 0.00617. The spread of
the Normal distribution is due to the large negative and positive slope
values about the overall mean as shown by the data. In all the slope
analysis the standard errors were 7 to 10 times larger than the Mean
Slopes, supporting the overall purely statistical conclusion, provided by
the Papworth (1975) Poisson Tests, that 1.) a simple linear fit to all the
pooled data sets is inadequate and the a priori assumption of LNT can
not yield a reasonable, single linear dose response between lung can-
cer risk and radon exposure at domestic and workplace levels 2.) there
are other mechanisms affecting the Human Lung Cancer Risks as
determined by the case-control studies. We also used a second, more
recent, Poisson Validation program, NETA also based on Edwards et al
B. E. Leonard and others
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(1979), available through the Inter-net and obtained the same results
and conclusions.
3.3 The Fit of the Krewski et al (2005, 2006) and the Darby et al (2005,
2006) Case-Control Lung Cancer Studies Data to Polynomials
Allowing for non-linearity, without a presumption that it be from adap-
tive response radio-protection, we have then used MML to trial fits of all the
data sets to 3rd, 4th and 5th degree polynomials, a + bX + cX2 + dX3 + eX4 +
fX5, which thus allows for considerable non-linearity if the data so dic-
tates.We have fit the Darby et al (2005, 2006) data plus China (Blot et al
1990) data to these polynomials. The best fits to the data sets are shown in
Figure 4 with the 95% confidence limits. For the high risk data set, a 5th
degree polynomial gave the best results with the polynomial coefficients: a
= 0.93, b = 4.84 E-04, c = 4.87 E-05, d= -2.74 E-07, e= 5.03 E-10, and f = -2.97E-
13, with an adjusted R2 = 0.420. These are shown as Figure 4A, for the high
risk group. In Figure 4B, for the low risk group, we found a 5th degree poly-
nomial provided the best fit with a = 0.836, b = 1.07 E-03, c = 4.85 E-05. e =
9.23 E-10 and f= -6.56 E-13, with an adjusted R2 = 0.254. For the overall
Darby et al (2005, 2006) data, we find a = 0.94, b = -9.28 E-04, c = 6.59 E-05,
d = -3.67 E-07, e = 6.72 E-10, and f = -3.94 E-13 with an adjusted R2 = 0.392.
We see a significant resemblance to the alpha particle dose response data
presented and analyzed in Appendix A of Part I and low radon concentra-
tion region of the representative alpha particle dose response shape in
Figure 10 of Part I. We analyze this in more detail in Section 4.1.
For both the high and low risk group Krewski et al (2005, 2006) plus
MA (Thompson et al 2008) polynomial fits, we found that a 2nd degree
polynomial provided the best fit because their data only goes to about 300
Bq m-3.(i.e. >200) in Table 1. As Figure 4C, we show the pooled CT, UT-
ID, MO-I, MO-IIg, Winn and IA positive sloped high risk data sets, with
the polynomial coefficients a = 0.987, b = 4.14 E-03, c = 9.51 E-05, d = -
2.15 E-07, e = 1.22 E-09, and f = -2.02 E-12, with an adjusted R2 = 0.223. As
Figure 4D, we show the 2nd degree MML fit for the low risk pooled MA,
NJ and MO-IIa negative responding sets. The coefficients are a = 0.94, b
= -4.69 E-02, c = 8.07 E-06, with an adjusted R2 = 0.326. Again we see a best
fit curve in Figure 4C that resembles the representative alpha particle
dose response shape in Figure 10 of Part I. For both the Darby et al (2005,
2006) plus China (Blot et al 1990) and Krewski et al (2005, 2006) plus MA
(Thompson et al 2008), we see the non-linear downward concave behav-
ior expected for Bystander Damage predicted by the microdose BaD
Model [Equation (2) and Figure 3 of Part I].
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3.4 The Fit of the Case-Control Lung Cancer Studies Data for MA, NJ and
MO-IIa to the Microdose Model
Using the original basic Microdose Model for adaptive response radio-
protection (Leonard 2007a), it has been shown, with some examples given
above in Figure 1 of Part II, for numerous Adaptive Response behaving
dose response data sets (Leonard 2008b), that when AR is activated by a
Poisson distributed single low LET induced charged particle tracks
B. E. Leonard and others
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FIGURE 4. Two pooled data sets, from Table 1 and Figure 1, fit to polynomials using the Method of
Maximum Likelihood. Panel A – Fit of 5th degree polynomial to all of the Darby et al (2005, 2006)
and China (Blot et al 1990) case-control data. Panel B – The positive, high risks case-control data sets
(Darby et al 2005, 2006) (Austria, France, Czech Republic, Eastern Germany, Sweden nationwide,
Sweden Stockholm, Sweden never-smokers, Southern Finland and Italy) fit to 4th degree polynomi-
als. Panel C – The pooled data fit for the low risk Darby (Darby et al 2005, 2006) data sets (United
Kingdom, Western Germany, Spain, Finland nationwide and also China (Blot et al 1990)) to 3rd
degree polynomials. Panel D – The North American (Krewski et al 2005, 2006) positive, high risks
case-control data sets (CT, MO-I, MO-IIg, IA, UT-ID and Winn) fit to 4th degree polynomials. Panel
E – The pooled data fit for the low risk North American (Krewswki et al 2005, 2006) data sets (MA,
NJ and MO-IIa) to 3rd degree polynomials. 
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through each cell, the AR protection dominates the response with a dose
response level below the zero dose level or below a Relative Risk of unity
in the AR Microdose Model Equation (3) in Part II. It would be very sig-
nificant if radon induced human lung cancer is indeed sensitive to
Adaptive Response radio-protection mechanisms from the low LET natu-
ral background and man-made human radiation exposures. For this rea-
son, in our study it was important to examine any possible direct correla-
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FIGURE 5. Adaptive Response Micodose Model fit to MA (Panel A and Panel B), NJ (Panel C and
Panel D) and MO-IIa (Panel E and Panel F) data (Krewski et al 2005, 2006). Shown are the Poisson
Thresholds for activation of the adaptive response protection and the linear slopes from Krewski et
al (2005, 2006) and the BEIR VI (1999) Lung Cancer Relative Risk. 
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tion providing evidence of this. To date, no justifiable reason has been
shown for the very large variation in the incidence of human lung cancer
with residential radon levels based on the case-control studies as we have
shown in Figures 2A through 2F. We, in Figures 5A through 5F, show the
use of the original basic Adaptive Response Microdose Model [Equation
(3) of Part II] to evaluate Adaptive Response radio-protection as a possi-
ble and probable cause of the non-linear, “U” shaped negative response
seen in the MA, NJ and MO-IIa data. Shown in the fits are the linearized
dose response as predicted by the BEIR VI (1999) Report (slope 0.19 per
100 Bq m-3) and the linearized response obtained by Krewski et al (2005)
(slope 0.176 per 100 Bq m-3). We have used a linear coefficient of 0.00176
for the α in Equation (3) of Part II i.e. α = 0.00176 lung cancers per Bq m-
3 of radon. Shown are two graphs for each of the MA, NJ and MO-IIa data
for low radon exposure levels to 250 Bq m-3 and for a high radon range
showing the transition to a linear response dictated by the value of α.
Referring to Figure 2 of Part II and the three damage regions, Bystander
Effect Region, Adaptive Response Region and Direct Damage Region that
were so useful in evaluation of AR protection for mammogram and diag-
nostic X-rays (Leonard and Leonard 2008), for lack of data, we simply esti-
mated the Direct Damage threshold and transition to the high radon lin-
ear region. We also assumed that at high radon levels that the Adaptive
Response protection is dissipated i.e. f(M) → 0 in Equation (3) of Part II
as observed in earlier evaluated data. There are not enough data to dis-
tinguish between AR protection for the spontaneous, priming dose and
radon cancer incidence. As discussed in detail in Leonard (2008b), this
has been the case for other Microdose Model analysis. Also, the data is
insufficient to detect any possible very low level Bystander Effects, either
deleterious or protective [although the low part of the negative responses
could be protective Bystander as observed in Leonard (2008a, 2008b)].
The resolved best fit parameters, to ± 31%SD, for MA in Figures 5A and
5B are: S related to a threshold of 34 Bq m-3, Pprot-pr∞ = 0.76 (76% AR pro-
tection) and α = 0.00176 per Bq m-3 [note that the Thompson et al (2008)
≥ 250 Bq m-3 data point provides a good fit to α ]. For NJ in Figure 5C and
5D, the resolved best fit parameters, ± 11%SD, are: S is related to a thresh-
old of 80 Bq m-3, Pprot-s∞ = 0.49 (49% AR protection) and assumed α =
0.00176 per Bq m-3. For MO-IIa in Figures 5E and 5F, the resolved param-
eters, to ± 10%SD, are: S related to a threshold of 82 Bq m-3, Pprot-s∞ = 0.78
(78% AR protection) and assumed α = 0.00176 per Bq m-3. We use the
term “related to” for the values of S since in Part I we have found that a
Normal Distribution is needed for the threshold. We have shown a possi-
ble correlation between low LET external terrestrial, internal Radon prog-
eny beta and 40K and external cosmic radiations. What is apparent, from
these case-control data analysis presented here, is that the data show that
there must be more than just the Linear No-Threshold dose response
B. E. Leonard and others
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mechanism affecting human lung cancer risks. This other mechanism
must be the protective mechanism provided by the adaptive response
effect as a result of the wide variation in geological and ecological condi-
tions existing worldwide as shown by the large variations in natural back-
ground and man-made radiations predicted in Section 3.1 and Figures 8
through 12 of Part II.
4. ANALYSIS
4.1 Recent Case-Control Studies and Pooled Data – Variability of Human
Lung Cancer Risks from Radon
We have used Figures 2A through 2F to show the very large range of
results, fit to a linear model, for the European pooled data of Darby et al
(2005, 2006) and Shengyang, China (Blot et al 1990) (Figure 2A – 2C)
data and the North American pooled data of Krewski et al (2005, 2006)
and Thompson et al (2008) (Figures 2D – 2F). Due to the very large vari-
ations in the linear fits to both pooled data sets, we have used the
Papworth (1975) Poisson Validation Test to statistically analyze the data
We refer to the Poisson Validation Test relative to Papworth because he
was one of the first to propose the Method of Maximum Likelihood pro-
cedure for fitting experimental data and the Poisson Test to validate the
data sets (Papworth 1975, Savage and Papworth 2000, Edwards et al
1979). The Papworth Poisson Validation Test indicated that both the
pooled data of Krewski et al (2005, 2006) and Darby et al (2005, 2006) to
be over-dispersed and assessed to be “contaminated” by other auxiliary
influences, as shown in Figure 3. Allowing for non-linearity, without a pre-
sumption that it be from adaptive response radio-protection, we have
then used MML to trial fit to all the data sets to 3rd, 4th and 5th degree
polynomials, a + bX + cX2 + dX3 + eX4 + fX5, showing considerable non-
linearity. These polynomial fits are shown in Figure 4 showing very sig-
nificant resemblance to the non-linear representative alpha particle dose
response shape of Figure 10 of Part I and in particular the Bystander
Damage Region. As we noted above, in the pooling of data from these
studies, the pool participants basically applied a crucial assumption that
between-site differences seen in the observed relationship between lung
cancer risk and radon exposure are due to random measurement vari-
ability and the true relationship is independent of site locality and only
dependent on the carcinogenic sensitivity of human lung tissue to alpha
radiation (which is assumed to be an invariant and Linear with No-
Threshold). The polynomial fits to these case-control data conclusively
shows that their assumption is invalid. The fit of the original basic AR
Microdose Model, in Figure 5, to the negative responding data from the
MA, NJ and MO-IIa studies indicates that there is negligible lung cancer
risks and the presence of a dominating adaptive response radio-protec-
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FIGURE 6. The polynomial Method of Maximum Likelihood fits to the high risk groups data for
both thr Krewski et al (2005, 2006) plus MA (Thompson et al 2008) and the Darby et al (2005, 2006)
plus China (Blot et al 1990) data. Panel A – The 5th degree polynomial fit to both the Darby/China
(Darby et al 2005, 2006, Blot et al 1990) and the Krewski/MA (Krewski et al 2005, 2006, Thompson
et al 2008) high risk group data. The circled area, labeled “1” is the low region where the low data
shows minimal increase in risk. The area labeled “2” is most probably where the Threshold and
Transition to the Direct Damage response occurs. The Darby (Darby et al 2005, 2006) high and low
risk groups required 5th degree polynomial fits. The Krewski (Krewski et al 2005, 2006) plus MA
(Thompson et al 2008) high risk group data fit to a 3rd degree polynomial. Only a 3rd degree fit was
needed since the data extends only to within the Bystander Damage Region to 250 Bq m-3. 
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tion from any radon progeny inducing lung cancer and naturally occur-
ring spontaneous (non-radon) lung cancers.
As Figure 6, we examine the polynomial fits to the high risk groups
for the Darby et al (2005, 2006) and the Krewski et al (2005, 2006) data.
The Figure 6A Darby et al (2005, 2006) high risk group polynomial fit
shows very similar characteristics to the alpha particle dose response data
analyzed in Part I, the representative alpha particle shape curves in
Figure 10 of Part I and the composite BE and AR Microdose Model esti-
mates in Figures 16 and 17 of Part II considering Adaptive Response pro-
tection from lung cancer from natural background and man-made radia-
tions. We thus label the three response regions i.e. Bystander Damage
Region, Threshold Region and Direct Damage Region as we have done in
our other BE and AR studies (Leonard 2008a, 2008b, Leonard and
Leonard 2008). Two areas are worthy of noting as 1 and 2 on the Figure
6A graph. Area 1 shows a flat region in the beginning caused by the low-
est radon category, where most values are 1.00, designated as slightly
above zero radon, but technically should be considered as a data point at
zero radon level. Correlating with the representative Figure 8, Part I
curve, the area 2 is most likely the single to double alpha traversal thresh-
old and transition region into the Direct Damage Region (see Section
4.1.a of Part I). We have included in the graph the curve from Figure 16A,
Part II (as “BE Microdose Model”), which is the estimated Relative Lung
Cancer Risk at the UNSCEAR (2000) worldwide average human back-
ground, low LET exposure. Significantly, the Figure 16A, Part II curve was
shifted slightly to provide a good correlation and gives an indication of
the radon concentration level that the radon cancer Direct Damage
begins in the dose response. Figure 6B provides the high risk group poly-
nomial fit from the pooled North American (Krewski et al 2005, 2006)
data. Their data points only extend to 250 Bq m-3, so they provide just the
Bystander Damage Region cancer risk. Figure 6C shows, with both the
Darby et al (2005, 2006) plus China (Blot et al 1990) and Krewski et al
(2005, 2006) plus MA (Thompson et al 2008) high risks fits, that the two
are in extremely good agreement.
The two low risk data groups polynomial fits are shown in Figures 4C
and 4E. The low risk fit for the North American (Krewski et al 2005, 2006)
data for MA, NJ and MO-IIa, in Figure 5, show a very large adaptive
response protection and no resemblance of a Bystander Damage Region,
Threshold Region or Direct Damage Region (although the Direct
Damage would not be seen for the highest 250 Bq m-3 data points). This
suggests a complete adaptive response protection that negates the alpha
particle lung damage, but further provides beneficial protection from
naturally occurring, spontaneous (non-radon) lung cancer risk from
endogenic toxic chromosome damage or hereditary lung cancers (since
they are lower than the zero radon concentration risks). The Darby et al
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FIGURE 7. Analysis of the MML polynomial fits. Panel A – Shown are the high and low risk group fits
for the Darby/China (Darby et al 2005, 2006, Blot et al 1990) data. Both curves show the behavior depict-
ed by the Representative Shape Microdose Model in Figure 10 of Part I. The lower cuvre is from reduc-
tion of cancer risk by adaptive response suppression. Panel B – We show the Representative Shape from
Figure 10 of Part I superposition on the high risk data fits. Here we show that the Darby/China (Darby
et al 2005, 2006, Blot et al 1990) low risk curve also conforms to the same shape behavior but at further
reduced levels. We estimate the relative lung cancer risk. The top curve would be with no adaptive
response protection. The two middle curves are the observed high risk and low risk Darby/China (Darby
et al 2005, 2006, Blot et al 1990) fits showing relative adaptive response protection. Panel C – The poly-
nomial fits to the case-control data show excellent agreement with the Representative Shape composite
Bystander and Adaptive Response Microdose Model given in Figure 10 of Part I, which is primarily based
on relative chromosome aberration incidence rates. The “U” shaped behavior of the case-control data
provides an indication of the radon concentration at which the single hit occurs for lung cancer induc-
tion. James et al (2004) provides estimates of the correlation between single alpha particle traversals per
kBq m-3 of indoor radon exposure per 30 lung cell mitotic cycle. They provide data for both the nucle-
us and separately the entire cell (cytoplasm hits). It would be expected that this single hit cancer induc-
tion level, shown to be at about 490 Bq m-3, would be greater than the James et al (2004) values. We show
in Panel C the James et al (2004) radon concentration single hit values for the indicated traversals for
the indicated lung cells. Only the single hits for the Bronchial and Bronchiolar Secretory cells are below
the Estimated Single Hit Cancer Induction concentration. This suggests that the sensitive volume for the
human lung cells for lung cancer induction may be the entire cell. Based on the adaptive response analy-
sis presented in Appendix B and Section 3.2, all data groups suggest some AR protection i.e. the
Darby/China (Darby et al 2005, 2006, Blot et al 1990) and Krewski/MA (Krewski et al 2005, 2006,
Thompson et al 2008) high risk groups 27%, the Darby/China (Darby et al 2005, 2006, Blot et al 1990)
low group about 72% protection and the Krewski/MA (Krewski et al 2005, 2006, Thompson et al 2008)
low group about 100% protections. Panel D – Illustration as to why a 3rd degree polynomial was adequate
for the Krewski/MA fit and a 5th degree polynomial was needed for the Darby/China (Darby et al 2005,
2006, Blot et al 1990) data. In the Bystander Damage Region the concave curvature is easily fit with 3 dif-
ferent slopes, whereas for the Darby/China (Darby et al 2005, 2006, Blot et al 1990) data extending to
the Direct Damage Region the three Bystander Region slopes are needed but a slope for the Threshold,
the Transition and the final Direct Damage slope. 
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(2005, 2006) low risk data fit shown in Figure 4C, which includes Western
Germany, Spain, Finland nationwide and China, shows the same charac-
teristics of a combined Bystander and AR protection as the Figure 4B for
the high risk data but lower in lung cancer risk. To compare the two fur-
ther, we show them together in Figure 7A where we see a distinct greater
adaptive response protection for the low risk group (as would be expect-
ed). In Figure 7B, we show fits to the Figure 8, Part I representative shape
curve but imposing an additional AR protection reduction seen by the
blue solid curves. We show the high risk curve for the equivalent Darby et
al (2005, 2006) and Krewski et al (2005, 2006) data (solid black) and the
Darby et al (2005, 2006) low risk curve (solid red) together in Figure 7C,
indicating various degrees of adaptive response protection as compared
to the risk without any AR protection (top curve). Based on our calcula-
tions in Part II, we estimate that the high Darby et al (2005, 2006) and
Krewski et al (2005, 2006) data show an adaptive response radio-protec-
tion of about 27%. For the low Darby et al (2005, 2006) data there is an
AR protection of about 72% and for the low Krewski et al (2005, 2006)
plus MA (Thompson et al 2008) data the protection is about 100%. In
Panel D of Figure 7, we show for the Darby et al (2005, 2006) data why a
5th degree polynomial was required for the best fit. Five different slopes
were encompassed in the fit to the Odds Ratio data.
4.2 New Evidence About the Cellular Sensitive Volume for Human Lung
Cancer Induction From Radon
We have cited the recent reassessment of the alpha particle dosimetry
for the BEIR VI (1999) report by James et al (2004) in Part I. The impor-
tant 30 day lung cell mitotic cycle single particle hit probabilities are
given in their Table 12. The ICRP (1994) Report 66 values as given in
James et al (2004) Table 12 are 0.36, 1.4 and 0.51 hits per Basal, Bronchial
Secretrory and Bronchiolar Secretory cells respectively per kBq m-3 of
radon for cell nucleus hits and 1.0, 16, and 4.0 hits per Basal, Bronchial
Secretrory and Bronchiolar Secretory cells respectively per kBq m-3 of
radon for cell cytoplasm hits (entire cell as “target”). As Figure 4 of Part
I, we have provided graphs of the variation in single alpha hit probabili-
ties for the three primarily alpha induced cancer sensitive cells in the
lung i.e. the Bronchial Basal, the Bronchial Secretory and the
Bronchiolar Secretory cells. In Figure 10 of Part I, we provide the corre-
lation between radon concentrations and Specific Energy Hits for these
three cell species for the nucleus and entire cell volumes relative to the
representative alpha particle dose response shape response. In Figure 10
of Part I, we show the alpha traversal rates for the BEIR VI (1999) radon
concentration frequency distribution in US homes and in Figure 12 of
Part I, we show the sensitive cells hit rates for the BEIR VI (1999), Figure
3-2 lung cancer relative risks. The Figure 7, Panels A, B and C show that
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the “U” shaped Direct Damage Threshold and Transition Region occurs
at a radon concentration of about 450 Bq m-3. This radon concentration
value then can be deemed as approximately the single to double hit tran-
sition for Direct Damage lung cancer induction concentration. In Figure
7C, we show this accordingly as the “Estimated Single Hit Cancer
Induction” level. From the analysis of the alpha particle micro-beam and
broad-beam data in Appendix A of Part I, we developed a representative
alpha particle dose response shape in Figure 10 of Part I which we felt typ-
ifies alpha particle produced neoplastic transformation and chromosome
aberration production for the 6.00 and 7.69 MeV radon progeny alphas.
We have marked the Bronchial Secretory cytroplasm, the Bronchiolar
Secretory cytoplasm, the Bronchial Secretory nucleus and the Basal cyto-
plasm on the Figure 7C graph, from James et al (2004) Table 12. In
Figure 10 of Part I, we have also provided different abscissa scales for con-
version to effective radon concentrations for hits to the three sensitive
cells and separately as to whether the nucleus or the cytoplasm are hit in
the 30 day mitotic cycle. The Basal nucleus and Bronchiolar Secretory
nucleus are 2778 Bq m-3 and 1960 Bq m-3 and would be off scale on the
Figure 7C graph. By basic definition of the Direct Damage Region and
the Direct Damage Threshold, we would expect that one or more alpha
particle traversals to occur to produce the threshold for Direct Damage
production of lung cancer in humans. We would expect that the radon
concentration for the single hits per kBq m-3 values to fall below the esti-
mated lung cancer single hit lung cancer induction value in the “U”
shaped region. We therefore must significantly conclude that either the
estimated single hit values for nucleus traversals from ICRP (1994)
Report 66 and James et al (2004) are incorrect or the sensitive “target” for
lung cancer induction is larger than just the cell nucleus. Wu et al (1999)
and Shao et al (2008) have observed induction of bystander responses by
targeting the cytoplasm. Based on Figure 7C, our analysis of the case-con-
trol studies supports their work that the sensitive cell volume for lung can-
cer induction in humans may be the entire cell of the three sensitive lung
cell species.
4.3 Mechanisms and Responses for a Non-Linear Human Lung Cancer Risk
We have shown that most probably there is a significant role of the
Adaptrive Response radio-protective mechanism in explaining the very
large variation in dose response results for human lung cancer risk from
case-control studies world-wide. Leonard (2008b) extensively reviews the
data showing that low LET radiation induced, Poisson distributed, single
charged particle traversals though target cells activates the protective
mechanism against potentially carcinogenic, exogenic large radiation
challenge dose damage and also against non-radon, endogenic, toxic,
naturally occurring, spontaneous chromosome damage. The radon prog-
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eny alpha particle damage can be viewed as exogenic challenge dose
damage. The fact that some case-control data, such as the MA, NJ and
MO-IIa data, show a reduction below the zero radon, natural sponta-
neous level means that the human low LET background and man-made
radiations also provide protection against the endogenic toxic sponta-
neous chromosome damage in the lung tissue.
Much is not known to explain the protective behavior. It is well con-
firmed that single traversals activate AR. Redpath and Elmore (2007)
report that the Reactive Oxygen Species concentration is reduced during
AR protection, so perhaps the very small amount of free radicals from the
single traversal activates the production of cell chemicals that quench the
spontaneous and radiation produced radicals such as hydrogen peroxide.
It is known that in AR protection ATM is activated and a G2 arrest is ini-
tiated. The distinction between the type of chromosome damages by the
bystander signals and from direct alpha hits are not clearly known. Also,
is there a distinction between the type chromosome damage from an
alpha particle traversal through the cell nucleus and the cytoplasm?
Cancer development involves a multi-stage process so the off-set between
the alpha particle hit rates and cancer induction suggested in Figure 7C
may be reconciled.
5. DISCUSSION
5.1 Use of the Papworth (1975) Poisson Validation Test
One can argue that it is inappropriate to apply the Papworth (1975)
Poisson Validation Test to the case-control data by use the risk data points
variation from the linearized slope curve, which is a continuous function
of radon concentration. In Section 3.2, we have argued that with the very
large case and control populations justifies the assumption that the lin-
earized curve represents a very accurate quantitative estimate of the “true
relationship (between human lung cancer risk and radon concentration)
independent of site locality”.
5.2 Validity of In Vitro Dose Response Studies in Predicting In Vivo
Radiation Effects
There is always the question of validity of in vitro cellular dose
response results, when applied to anticipated radiation dose response in
humans. Tissue cultures first came into use in the study of radiation dose
response relative to cancer radiation therapy. For radio-therapy, of par-
ticular concern was the cell killing radiosensitivity and cell recovery
(repair) capability of tumor and peripheral tissue and organs. In the
1970s with newly developed in vitro cellular techniques, the research
group at Columbia University directed by Dr. Eric Hall (Hall 2000) per-
formed in vitro dose and dose rate dependent studies of a number of new
Radon Case-Controls - Adaptive Response and Bystander Effects
437
23
Leonard et al.: Radon Case-Controls - Adaptive Response and Bystander Effects
Published by ScholarWorks@UMass Amherst, 2014
mammalian cell species. Dr. Halls (Hall 2000) group was meticulous to
obtain many different dose rates data sets with dose rate data as low as 10
cGy h-1. These data were found to be useful in our “Inverse” Dose Rate
Effect studies (Leonard 2000, 2007a, Leonard and Lucas 2008, 2009).
The cell species studied were V79 log phase, V79 plateau phase, HeLa log
phase, C3H 10T1/2 plateau phase, C3H 10T1/2 log phase, CHF-F log
phase, rat kangaroo, Munt Jac, pig kidney and L-P59 cells. As more
human in vitro cell strains became available, in vitro dose rate response
studies were possible with direct human application to continuous pro-
tracted (brachytherapy) and fractionated radiotherapy. Thus, in the
1980s, there were dose and dose rate surviving fraction in vitro dose
response measurements on numerous human cell tissues, many of them
by Dr. Gordon Steel (Steel et al 1987) and his radio-biology research
group. In a review article by Steel et al (1987), the dose response of
human tumor cell lines were summarized i.e. HX34 melonoma, RT112
bladder, HX118 melonoma, HX142 neuroblastoma, HX156 cervix carci-
noma, HX138 neuroblastoma, GCT27 testis, HX58 pancreas, WX67 blad-
der and HX143 neuroblastoma.
In support of the Hall (Hall 2000) and Steel (Steel et al 1987) groups
work, the dose and dose rate analytical models of Thames (1985)
(Incomplete Repair - IR) and Curtis (1986) (Lethal Potential Lethal –
LPL) Models (see Table II Steel et al 1987) were developed. Only two or
three separate dose rates were sufficient to determine the α (single hit L-
Q damage rate per unit dose), the β (double hit L-Q damage rate per
square of dose) and the mean repair half-time, T1/2 (in hours). A more
complete list of these parameters for 38 cells of human origin is provided
in Table 1 of Brenner and Hall (1991). Small numbers of dose rate data
sets were adequate to determine these three parameters. For example in
terms of dose rate data sets, Kelland and Steel (1986) provided data for
four human tumors with only two dose rates (acute 150 cGy/min and 1.6
cGy/min) for HX58 and HX32 (both pancreatic carcinoma) and only
three dose rates (acute 1.50 Gy/min, 7.6 cGy/min and 1.6 cGy/min) for
HX118 melonoma and HX99 breast carcinoma. Similarly, McMillan et al
(1989) provided two dose rate data sets for the human neuroblastoma
cells HX142 and HX138 (acute 1.8 Gy/min and 1 cGy/min). Cassoni et
al (1992) obtained only two dose rate data sets for four human lung car-
cinomas (two small-cell and two non-small cell, HC12, HX149, HX147A7
and HX148G7. Stephens et al (1987) provided 4 dose rate data sets for
HX34 human melanoma and 6 data sets for MT mouse mammary carci-
noma which we were able to use with their isodose curves in our earlier
studies (Leonard 2000, 2007a) as non-IDRE responding cells. Furre et al
(1999) only provided three dose rate data sets for the human cervix car-
cinoma cell line NHIK 3025, but fortunately the lowest dose rate data set
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at 33 cGy h-1 showed a significant hyper-radiosensitivity as compared to a
higher dose rate of 94 cGy h-1.
There are several tools, developed in the late 1980’s and 1990’s, that
have been used by radiotherapists for evaluation of human tissue dose rate
effects primarily for low dose rate (LDR) and high dose rate (HDR)
brachytherapy treatments and high dose rate fractionation. They are first
the isoeffect dose rate curves for constant surviving fraction which were
utilized early in radiotherapy analysis. The second major tool was the dose
and dose rate dependent cell radiation response models cited above. From
these modeling sources, various parameters are obtained from fit of these
models to laboratory measured in vitro dose rate response data i.e. α / β
ratios for the linear-quadratic model and the biological effective dose
(BED) (Jones et al 2001). Due to dose rate effects, it has been known that
there is a therapeutic advantage between tumor control and normal tissue
complications for fractionation or protraction (brachytherapy). For exam-
ple, it has been found that typically high α / β ratios, determined from
model fitting to in vitro data, are characteristic of normal peripheral tissues
that show an early deleterious response in fractionated treatments (see
Chapter 22, Hall 2000). Recent analysis of α / β ratios for prostate carci-
noma cells are reported (Brenner et al 2002, Carlson et al 2004) that show
low α / β ratios and high radio-sensitivity similar to late responding tissue.
In Figure 3 of Brenner (1997), a distinction is made between early
responding and late responding human tissues (steeper slopes) using iso-
effect curves for brachytherapy as well as for fractionation. In vitro cellular
dose response measurements and the application of the BED, IR and LPL
Models are still extensively used in radio-therapy treatment planning (Hall
2000, Brenner et al 2002, Jones et al 2001).
Hyper-radiosensitivity to cell-killing at very low doses was first
observed from in vitro cellular dose response data and is now extensively
studied with respect to radio-therapy of solid tumor treatment (Marples
et al 2004). This effect has been labeled Hyper-Radiosensitivity and
Induced Radio-Resistance (HRS/IRR). It has been found, with the in vitro
studies, that about 80% of cell species studied (Dasu and Denekamp
2000) experience HRS/IRR. This is found to be true for 45 human cell
species (Joiner et al 2001). In radiotherapy, this very low dose hyper-
radiosensitivity is being examined for possible therapeutic gain by the use
of ultra-fractionated dose from 0.5 to 1.5 Gy instead of the fractionated
doses of 2.0 Gy in conventional radiotherapy treatment regimes (Slonina
et al 2007, Harney et al 2004a, 2004b). Conclusive in vitro benefits for
head and neck cancers have been shown and potential benefits for brain
glioma cancers are suggested (Dey et al 2003, Tome and Howard 2007).
The University of Kentucky Markey Cancer Center has recruited head
and neck tumor patients for a bi-weekly combined gemcitabine and pacli-
taxel and low-dose radiation treatment program using 50 to 80 cGy twice
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daily (4 hours apart) radiation exposures ( see internet ClinicalTrials.gov
Identifier NCT00176241). From in vitro data correlating IDRE with the
HRS/IRR hyper-radiosensitivity (Leonard 2000, 2007d), it is suggested
that the “Inverse” Dose Rate Effect hyper-radiosensitivity may cause exces-
sive cell killing in LDR brachytherapy of preferential tissues and organs
but also may have a therapeutic gain if tumor cells undergo IDRE
(Leonard and Lucas 2008, 2009).
In the last 25 years, on the order of thousands of oncogenic neoplas-
tic transformation and chromosome aberration in vitro studies have been
reported with the presumption of a correlation of in vitro data with
human carcinogenesis. Based on the extensive studies of in vitro alpha
particle cellular dose response to ionizing radiations (Miller et al 1995,
1999, Zhou et al 2001, 2004, Nagasawa and Little 1999, 2002, Nagasawa et
al 2003, Hei et al 1997, Sawant et al 2001) and analyzed in Part I, there
has been a presumption that the Bystander Effect is experienced by
humans in the induction of radon induced lung cancer (Zhou et al 2001,
Brenner et al 2001, Brenner and Sachs 2002, Little and Wakeford 2001,
Little 2004). The extensive Adaptive Response in vitro research cited here
(Azzam et al 1996, Elmore et al 2006, 2008, Ko et al 2004, Redpath et al
2001, 2003, Redpath and Antoniono 1998, Shadley and Wiencke 1989,
Shadley and Wolff 1987, Shadley et al 1987, Wiencke et al 1986, Wolff et
al 1989, 1991) and analyzed with the composite AR and BE Microdose
Model (Leonard 2005, 2007a, 2007b, 2008a, 2008b, Leonard and
Leonard 2008) is supportive of humans experiencing Adaptive Response
radio-protection from low LET radiation exposures. As shown in the next
section, there are more in vivo relatively new data supporting AR protec-
tion than BE damage in humans. It is generally accepted that the induc-
tion of carcinogenesis in the human anatomy can be predictable by in
vitro observation of cellular damage mechanisms.
5.3 In Vivo Examples of Adaptive Response Radio-protective Dose
Response to Ionizing Radiations
Although we have in the previous section given examples of how in
vitro dose response data have assisted radio-biologist and radio-therapist
in anticipating human dose response to radiation and suggested that
these data support a premise of in vitro data that there are bystander and
adaptive response effects in humans, some critics have noted that little in
vivo data are available. We offer the following relatively recent in vivo
results. A number of animal laboratory exposures to ionizing radiations
have shown the ability of cells, tissues and organs to exhibit adaptive
response radio-protection from low doses. There are also some examples
of AR reduction effects for human exposures. We here cite a few of these
cases. Perhaps the most directly applicable case to AR reduction in lung
cancer incidence is the analysis conducted by Rossi and Zaider (1997) of
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FIGURE 8. Examples of reduction in lung cancer incidence below the zero-radon spontaneous level.
The red curves show the estimated Poisson distributed adaptive response activation. Panel A – The
data of Rossi and Zaider (1997) (Rossi 1999) of reduction in lung cancer for women treated for
breast cancer with radio-therapy. Panel B = The epidemiological data of Cohen (1997) of lung can-
cer incidence by counties in the US. Panel C - The observed lung cancer risk in a case=control study
of textile workers in Shanghai, China exposed to toxic textile chemicals (Astrakianakis et al 2007,
Levin et al 1987). 
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about 14,000 women that had received radio-therapy treatment for breast
cancer (we show their dose response data as Figure 8A, reproduced from
Figure 3B of Leonard (2007a). The epidemiological data of Cohen
(1997), presented here as Figure 8B, showing a reduction in lung cancer
incidence in the US with increasing radon levels, has generated 20 years
of controversy. His response curve is even shown in the BEIR VI (1999)
Figure 3-2 reproduced in our Figures 1C and 15 of Part I. Two non-radi-
ation case-control studies (Levin et al 1987, Astrakianakis et al 2007), the
data shown in Figure 8C for textile workers in Shanghai, China, found a
reduction in lung cancer risk of about 30% with increasing endotoxin
exposure. The first study involved 1405 cancer cases and 1495 controls.
Dr. Blot, who did the Shengyang, China radon case-control study (Blot et
al 1990), was a participant in this study. The more recent study involved
628 cancer cases and 3184 controls. These AR reduction findings are sim-
ilar to that of US textile workers (Henderson and Enterline 1973).
Although the studies did not involve radiation as the toxigen, it does sug-
gest an ability of lung tissue to activate protective mechanisms under
stress conditions.
The most recent, and believed to be most significant, studies have
been with live whole-body exposures of mice. Wang and Cai (2000) irra-
diated live mice to a 6 Gy challenge dose and found that with adminis-
tering a priming dose of 0.5 Gy 48 hours prior to the challenge dose, the
effect on red blood count, white blood count and platelet count was
reduced by 90%. Day et al (2006) exposed live pKZ1 mice prostate gland
to challenge doses of 1000 mGy of X-rays and measured the chromosome
inversion frequency. By pre-exposing the mice to very low doses of X-rays
( 0.001 to 10 mGy), a reduction of from 50 to 70% was observed with the
greatest reduction for the 0.001 mGy exposure. Two research groups have
examined the effect of low dose rate exposures, at rates comparable to
human dose rates. Ina and Sakai (2005) exposed MRL-lpr/lpr mice to a
chronic dose rate of 1.2 mGy/h for a series of prolonged exposure exper-
iments and studied the life-span effect. For life-long exposures, they
observed what has to be considered a remarkable result. The median life-
span of 134 days of unexposed mice was extended to 502 days from these
continuous exposures. At the dose rate used the exposed mice received
the equivalent annual NRC permitted dose for nuclear workers in 2 days,
and yet they survived for 502 days. With a series of experiments with can-
cer proned, Trp53 heterozygous mice, the dose rates were at levels that
occupational nuclear workers would be expected to receive under nor-
mal work conditions at sub-NRC levels. What has been shown is that for
these mice in vivo, such low doses induce an adaptive response that
increases tumor latency and increases the life span as shown in Figures 9A
and 9B ( from Mitchel et al 2003). These data show the adaptive response
radio-protection from endogenic, spontaneous, genetically inheritable
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tumor development. A low-dose threshold exists for the adaptive
response protection against chronic ulcerative dermatitis, a spontaneous,
autoimmune-type age-related disease in the C57BL/6 mice (Mitchel
2007b). For that non-cancer disease, these very low-dose fractionated
exposures induced a protective adaptive response in both Trp53 normal
and heteroztgous mice, but a lower threshold level of exposure had to be
exceeded. This shows that low doses of low LET radiation can activate
tumor protective mechanisms, but with a minimum threshold, just as we
have seen in the in vitro AR data in Figure 1 of Part II and our other work.
But also, there is a high dose threshold where the Direct Damage domi-
nates the AR protection., as also we have seen in our analysis of the in vitro
data and shown in Figure 5A of Part II at around 10 cGy of priming dose.
5.4 Some Special Considerations Relative to the Combined Bystander and
Adaptive Response Lung Dose Response
In a recent Dose-Response Journal review article (Leonard 2008b),
the various circumstances under which adaptive response protection can
be experienced was presented. In Section 2.3 of Part II, we have summa-
rized key AR responding data relative to protection from large “chal-
lenge” doses of radiation and from naturally occurring, potentially car-
cinogenic, spontaneous cellular damage. What occurs in the human lung
from radon progeny alpha particles can be perceived as alpha particle
“challenge” dose damage, which we have shown is modulated by the AR
from the continual human low LET exposures. In the laboratory, a “chal-
lenge” dose experiment, such as those performed by the Shadley,
Wiencke and Wolff research group (Shadley and Wiencke 1989, Shadley
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FIGURE 9. Study of low dose rate induction of adaptive response radio-protection (Mitchel et al
2003). Panel A – The appearance of spinal osteosarcomas associated with paralysis in Trp53 het-
erozygous mice (+/-) at low occupational level dose rate. Panel B – Tumor latency of lymphomas
appearing in unexposed Trp53 normal (+/+) and Trp53 heterozygous (+/-) mice exposed to indi-
cated doses of 60Co radiation. 
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and Wolff 1987, Shadley et al 1987, Wiencke et al 1986, Wolff et al 1989,
1991), is with a single large “challenge” dose. In assessing human cancer
risk from radon, we are examining a continuum of exposure data over a
wide range of alpha particle exposures to the lung. The analysis of the
Pohl-Ruling (1988) radon exposure data involved a case where the radon
progeny beta rays provided the low LET adaptive response protection.
There then was a case of a continuum of beta ray AR protection with
increasing radon exposure. We have included this beta source in our
analysis here in Part II. We have also had to consider, in Part II, the vari-
able increase in the Uranium terrestrial background radiation as a sec-
ond continuum source to AR protection.
5.5 Measurement of Indoor Gamma Ray Dose in Case-control Studies
The fact that underground miners lung cancer data may not be
directly applicable to human lung cancer incidence at domestic and
workplace radon levels means that case-control studies may be more sig-
nificant in the assessment of lung cancer risks from radon. The evidence
of adaptive response reduction of lung cancer risks from human expo-
sure to low LET radio-protection suggests that planners for future case-
control studies should consider the measurement of the indoor gamma
and beta ray exposure levels as well as the radon concentration exposures
in residences to assess AR protection. This would require portable gamma
ray spectrometer systems. There are basically two type spectrometers that
have been used. Clouvas et al (2001) used a high resolution Germanium
solid state detector system that yields gamma spectrum data similar to
that shown in Figure A1A of Part II. The USGS and DOE aerial monitor-
ing systems use a large NaI crystal as their detector (DOE 2002). This has
a much higher detection efficiency than the much smaller Germanium
detector and has been found to provide adequate resolution. The
Germanium system requires then longer counting times to obtain a good
spectrum. Portable automatic analyzer systems to resolve the individual
gamma rays and their intensities are available for both.
5.6 Uncertainties in the Estimation of Combined BE and AR Effects on the
Lung Cancer Risks from Radon
It has been found that the magnitude of the adaptive response pro-
tection below the zero priming dose response “challenge” damage or
spontaneous damage level varies between about 50% to about 80%. We
have used a 65% reduction for the priming dose reduction parameter
Pprot-pr [see Equation (3) and then Appendix A of Part II for the defini-
tion]. The relative sensitivities of the three lung cell species to carcino-
genesis is not accurately known (NRC 1991). It is suspected that the basal
cells may have greater sensitivity than the other two, but not conclusively
B. E. Leonard and others
444
30
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 3, Art. 13
https://scholarworks.umass.edu/dose_response/vol10/iss3/13
confirmed. We have here considered the three cells sensitivities as equal.
There are uncertainties relative to the size of these cells as targets for
charged particle traversal of both alphas and low LET traversals. We have
used the BEIR VI (1999) values as have others (Little and Wakeford 2001,
Brenner et al 2001, Little 2004, Brenner and Sachs 2002).
The compilation of lung cell Specific Energy traversals is conservative
in that the external beta rays from the terrestrial radiations are not
included, the 0.511 MeV annihilation gamma rays are neglected in the
internal Potassium-40 activities, only the cosmic ray high energy protons
are considered neglecting the approximately 10% high energy helium
ions and neutrons and also any variation in Thorium terrestrial gammas
with increasing radon concentration is neglected (USGS has only, so far,
provided in the NURE report the Uranium terrestrial data). We have not
considered any protective bystander effects even though there is evidence
from recent work presented in Section 2.3.b and Figure 2 of Part II. Its
presence would reduce the dose response at the very low dose region of
the radon dose response curve.
In Figures 1 and 5A of Part II, it is shown that the domination of the
Direct Damage component from priming doses in the adaptive response
experiments begins at about 10 cGy of low LET primer dose. It is also
shown throughout this work that the threshold for the adaptive response
protection begins with a Poisson distributed mean single Specific Energy
Hit. For the radiations tabulated in Table A1 of the Appendix A of Part
II, this would occur on an average at about 0.10 cGy such that the
Adaptive Response Region extends from about 0.10 cGy to about 10.0
cGy. With the UNSCEAR (2000) worldwide average human low LET
exposure at about 1.7 mSv (see Table 1), a significant fraction of the
human lung cells will have received a single low LET radiation induced
charged particle traversal, activating the AR against the radon progeny
alpha deleterious Bystander Damage.
The use of the modified BaD Model concave Bystander Damage dose
response for the domestic region radon alpha induced Radon Lung
Cancer Risk, without the presence of AR protection, provides an average
for the domestic region, in Figure 13B of Part I, which is higher than pro-
vided by the approximately 0.0020 ERR/Bq m-3 BEIR VI (1999) estimate.
For the radon range from zero to 400 Bq m-3 the average ERR using the
concave Bystander Damage dose response in Figure 13B, Part I is 0.818
compared to the BEIR VI (1999) average ERR of 0.676 for the same
range, meaning about a 20% higher lung cancer induction without AR
protection being considered.
We have shown that the 13 European case- control studies [plus the
Blot et al (1990) study in Shenyang, China] and the 8 North American
studies [plus the Thompson et al (2008) MA study] show such an extreme
variation, that either the case-control methodology is totally invalid
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(which most radiobiologist and the BEIR committees are reluctant to
premise) or that there are one or more other dose response mechanisms
other than the Linear No-Threshold mechanism. It is significant to note
that Krewski et al (2005, 2006), in their analysis of their study, indicates
that if the Iowa data is removed from the North American pooling, then
any statistically positive association between radon and lung cancer dis-
appears [e.g. the dose response slope, beta (95% CL) in our Equation
(C1), reduces to 0.04 (-0.04, 0.19) per 100 Bq m-3] (see their page 578).
Also, Darby et al (2005) shows no statistically significant Relative Risk
below 100 Bq m-3 as compared to the reference value below 25 Bq m-3 (see
their Table 2) and they suggest a possible threshold at 150 Bq m-3 (see
their paragraph 1, page 224). There seems to be considerable uncertain-
ty in their analysis and results. Another example is the case-control study
in Spain where Darby et al (2005) reports a negative slope whereas the
original publication (Barros et al 2002) reports a positive slope for beta
in Equation (1). The Spanish study of Llorca et al (2007) showing no cor-
relation between radon and lung cancer was not reported. There is a sub-
sequent China case-control report for the Gansu Province of China
(Wang et al 2002) that shows a positive Odds Ratio above 150 Bq m-3 but
was not included here. From Figures 16 and 17 of Part II, the mean and
maximum and minimum human lung dose responses from combined
radon progeny particles and low LET human radiation charged particle
traversals are shown.
Research data is emerging in support of abnormal cells as being a
key property of carcinogenesis and higher levels of organization such as
tissues and organs play an important role. The extensive in vivo mice
studies (Mitchel et al (1999, 2002, 2003, 2004, Mitchel 2006, 2007a,
2007b, 2008), show that adaptive response protection impacts on tumor
development and progression. Cancer does not however develop at the
tissue or organ level. It is universally accepted that cancers, including
lung cancer, starts in a single cell. BEIR VI (1999) acknowledges this. We
take the liberty to quote from the “Executive Summary” statement for
DOE’s Low Dose Radiation Research Program (DOE 1999). The sum-
mary begins “Each and every cell in the human body is constantly
engaged in a life and death struggle to survive “in spite of itself”.” Later
in the second paragraph in bold print it states “Thus, a crucial, yet unan-
swered, question in radiobiology is whether the biological damage
induced by low doses and low dose rates of radiation is repaired by the
same cellular processes and with the same efficiency as normal oxidative
damage that is a way of life for every living cell”. Even later in the sum-
mary it states “The research program will build on advances in modern
molecular biology and instrumentation, not available during the previ-
ous 50 years of radiation biology research, to address the effects of very
low levels of exposure to ionizing radiation. It will concentrate on under-
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standing the relationship that exists between normal endogenous
processes that deal with oxidative damage and processes responsible for
the detection and repair of low levels of radiation-induced damage.” It is
universally understood that the damage inducing carcinogenesis begins
solely within the cell, not tissue or organ, although these are impacted
by tumor development and metastasis.
This work highlights future research needs. Neither alpha particle
bystander nor low LET adaptive response or combined in vitro experi-
ments have been conducted, to a reasonable extent, directly with the
basal and secretory lung cells. The alpha particle LET and RBE broad-
beam in vitro experiments of Miller et al (1995) need to be repeated with
immortalized basal and secretory cells. Similarly, the low LET adaptive
response experiments of Dr. Redpaths group need to be repeated with
the immortalized basal and secretory cells. Very low doses should be used,
below the AR threshold <z1> values to examine protective bystander
effects. It is not known if there is a distinction between chromosome dam-
age from bystander signals and from Direct Damage.
With the hundreds of thousands of mice that have been sacrificed for
radon studies, none have involved simultaneous exposure to internal
radon progeny alpha lung and external low level low LET radiations, to
look for AR, as compared to just internal radon as controls [similar to Dr.
Mitchels priming exposures (Mitchel et al 1999, 2002, 2003, 2004,
Mitchel 2006, 2007a, 2007b, 2008) examining AR for other biological
“end-points”]. The problem however is that at the higher radon concen-
trations, such as used by Cross (1988), to accelerate cancer induction in
the animals, the doses are in the Direct Damage Region above the
Adaptive Response Region and even in the EDE region.
5.7 Use of Underground Miners Lung Cancer Risk Data for Domestic and
Workplace Radon Levels
From the work presented here, it would appear that extrapolation
from underground miners lung cancer risks (Lubin et al 1995a, 1995b)
to lower domestic radon level risks may be fundamentally inappropriate
due to the different type cellular damage involved i.e. Bystander Effect
Damage at domestic levels and Direct Damage at underground mine lev-
els (See Section 4.2.e of Part I). In Figures 10 and 12 of Part I and the
case-control results, it is shown that radon lung cancer induction at
human domestic and workplace radon levels is from bystander lung cell
damage. Based on our analysis, only above about 500 Bq m-3 of radon is
there evidence of Direct Damage induction of human lung cancer from
the case-control studies. In Figure 10, it is shown that the underground
miners were exposed to radon levels where multiple lung cell alpha tra-
versal were prevalent during the 30 day mitotic cycle and thus Direct
Damage and a different dose response shaped curve is experienced as evi-
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denced by Figures 10 and 12 of Part I. In fact the depth of the “U” shaped
behavior is deeper for the case-control, high risk response, indicating dif-
ferent lung cancer sensitivity for the two regions than predicted by the
representative shape curve in Figure 10 of Part I.
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FIGURE 10. Based on underground miners exposures presented in Figure 13A of Leonard (2007c),
We show Panel A – The percentile of mine workstations where one lung cell alpha particle traversal
will occur in the 30 day cycle. Panel B – Percentile of workstations where multiple traversals will occur.
Thus for the underground miners their lung cancer risks are from Direct Damage alpha particle tra-
versals not from Bystander Damage. 
34
Dose-Response: An International Journal, Vol. 10 [2014], Iss. 3, Art. 13
https://scholarworks.umass.edu/dose_response/vol10/iss3/13
5.8 Implications Relative to Human Radiation Exposures for the General
Public and Radiation Workers
The study has shown that low LET radiation exposures from environ-
mental and man-made sources and normal human activities can induce
cancer preventive adaptive response radio-protection mechanisms in
human lung tissues. These exposures are mostly whole body exposures
with doses on the order of fractions of a mGy per cell cycle for most cells
within the human body. The LET of the radiations as shown in Tables A1
and A2 of Part II are such that a significant portion of human cells
throughout the body will receive at least one radiation induced charged
particle traversal per cycle and thus experience a reduction in potential-
ly carcinogenic spontaneous cellular damage and damage from external
radiations, particular for radiation workers. We have, from Figure 1B,
Part I and Table 1 of the nuclear workers study by Cardis et al (2007),
examined the dose distributions of the cohorts included in their study.
We reproduce, as Figure 11A, the Cardis et al (2007) data for Excess
Relative Risk for cancer from three categories i.e. All Excluding
Leukemia, All Excluding Leukemia, Lung and Pleura, and Leukemia less
CCL. Below about 70 mSv exposure it is shown that there is either no risk
or a negative risk for all three categories. Figure 11B shows that 96% of
all workers received a lifetime occupational dose of less than 100 mSv (10
Rem). If we exclude those below 5 mSv, which may be clerical staff that
do not enter Radiation Areas, the value is 86%. In our past analysis of
adaptive response (see Figure 1 of Part II), we found that the threshold
for the Direct Damage component for neoplastic transformation and
chromosome aberration production begins at about 100 mGy.
5.9 The Ecological Concept for Population Weighting of Radon Radiation
Risks
We have shown that ecological and geographical conditions most
probably result, in some instances, a reduction in human lung cancer
risks from radon, below the natural occurring zero radon level. We have
included all the data in the 23 case-control studies and averaged the can-
cer risks in the radon exposure range from 0 to 400 Bq m-3 considered.
Although it is conclusive from the high risk data of Krewski et al (2005,
2006) and Darby et al (2005, 2006) that high levels of radon can cause
lung cancer it is also evident from the low risk data that a combination of
ecological and geological conditions can result in an epidemiological
decrease in lung cancers below the spontaneous, zero radon, level for
many of the worlds populations. Population weighing of the beneficial
with the deleterious aspects of radon may mean radon imposes negligible
risk to humans.
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5.10 A Threshold and Transition Behavior for Initiation of the Direct
Damage Region for Alpha Particles
From the application of the composite Microdose Model in Part I
alpha particle dose response data, it is found that single alpha particle tra-
versals through the cell do not appear to induce neoplastic transforma-
tion or chromosome aberrations. The fit of the model demands that
there be a threshold and transition involving a second alpha particle tra-
versal through the cell with increasing alpha particle fluence. The idea
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FIGURE 11. The Cardis et al (2007) nuclear workers study. Panel A – The low worker dose region
showing the Linear No-Threshold Model to be a poor assumption below about 60 mSv. Panel B =
Graph of Percent of total workers above the indicated dose showing 96% below 100 mSv and 89%
below 100 mSv if the < 5 mSv is neglected. 
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that more than single hits are necessary to activate the direct damage was
first suggested by Miller et al (1999) and here we use the Normal
Distribution simply to empirically shape the dose response curve in the
modified bystander BaD Model. Other causes such as a reduction in the
spontaneous damage level by single hits may be the plausible mechanism.
The best fit to nine separate data sets in Appendix A, Part I found that a
Normal Distribution accumulation function with a Mean value of 1.68 tra-
versals and a Standard Deviation of the distribution of 0.62 traversals pro-
vides this threshold and transition. Miller et al (1999) first observed this
characteristic in comparing single alpha particle microbeam exposures
with broadbeam exposures of 10T1/2 fibroblast cells. We have confirmed
that multiple traversals are necessary to induce cellular Direct Damage.
Miller et al (1999) commented that this may mean an overestimate of risk
at low doses using LNT would occur. We see however that bystander dam-
age occurs below multiple traversals, at domestic levels, but is, as they
note, non-linear and not accurate by LNT extrapolation. We see in the
analysis of the case-control studies of Krewski et al (2005, 2006) and
Darby et al (2005, 2006) that there is indeed a “U” shaped behavior in
their Odds Ratio Lung Cancer Risk curves as determined by our com-
posite Microdose Model analysis. The analysis of the Miller et al (1999) by
Brenner et al (2001) and Little and Wakeford (2001) is inappropriate as
shown in Figure 12 since a well-defined Bystander Damage Region would
be observed if exposures are performed in that region. This well-defined
behavior is clearly seen in Figures 10 and 16 of Part I.
6. SUMMARY
We believe that this three part study (Leonard et al 2010a, Leonard et
al 2010b and this Part III) provides the first direct evidence of bystander
and adaptive response effects on humans.
6.1 Summary of Parts I and II
We can tabulate the significant results of the prior Parts I and II analysis;
1. BEIR VI (1999) and Pooled Case-Control Studies Assumption of Lin-
earity for Human Lung Cancer Risks from Radon
The BEIR VI (1999) assessment of linearity for human lung can-
cer risks from radon is summarized in their Figure 3-2 and their
Executive Summary statement, repeated again here from the
Introduction Section as follows: “The choice was to use a linear rela-
tionship between risk and low doses of radon progeny without a
threshold. The choice was based primarily on considerations related
to the stochastic nature of the energy deposition by alpha particles;
at low doses, a decrease in dose simply results in a decrease in the
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number of cells subjected to the same insult. That observation, com-
bined with the evidence that a single alpha particle can cause sub-
stantial permanent damage to a cell and that most cancers are of
monoclonal origin, provides the mechanistic basis of the use of a lin-
ear model at low doses. In addition, as discussed in the report, expo-
sure-response relationships estimated from the observational data in
miners with low exposures, and from the case-control studies of
indoor radon, are consistent with linearity.” The BEIR VI (1999)
Figure 3-2 is provided as Figure 1C in the Introduction of Part I.
This assumption of linearity of risk is considered basic by the par-
ticipants in the recent North American (Krewski et al 2005, 2006)
and European (Darby et al 2005, 2006) pooled case-control studies
with their premise that “The pooling of data from these studies is
B. E. Leonard and others
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FIGURE 12. For reasons not presently known, the microbeam and broadbeam alpha particle dose
response data examined in Appendix A requires more than single alpha particle hits to initiate the
Direct Damage induced neoplastic transformation and chromosome aberrations. Below the single
alpha traversals the data shows a well-defined Bystander Damage response such as in Figure A1F.
Panels A and B – The data of Miller et al (1999) for microbeam and broadbeam exposures of 10T1/2
cells showing no Direct Damage for single microbeam hits. Bottom two Panels – Examination and
analysis by Brenner et al (2001) and Little and Wakeford (2001) showing inappropriate evaluation of
the Bystander Regions. 
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based on the assumption that between-site differences seen in the
observed relationship between lung cancer risk and radon exposure
are due to random measurement variability and the true relationship
is independent of site locality and only dependent on the carcino-
genic sensitivity of human lung tissue to alpha radiation.”, which both
the Darby et al (2005, 2006) and Krewski et al (2005, 2006) groups
assumed to be Linear No-Threshold (LNT) compatible with BEIR VI
(1999). We show their linear best fits in Figure 2 of Part I and Figure
1 herein.
2. Analysis of Micro-beam and Broad-beam Alpha Particle In Vitro
Measurements
The micro-beam and broad-beam alpha particle in vitro dose
response measurements, primarily at the Columbia University accel-
erator, show that at low radon levels human lung cancers should be
from Bystander Damage in human lung tissue (see Figure 10 and 16
of Part I). Thus the lung cancer Relative Risks dose response should
be non-linear according to the bystander BaD Model and not as
premised in 1. above by BEIR VI (1999) and Darby et al (2005, 2006)
and Krewski et al (2005, 2006).
3. Adaptive Response Radio-protection from Natural Background and
Man-made Radiation as Cause of the Very Large Variation in the
Pooled Case-Control Human Lung Cancer Studies
We have noted that low LET induced single charged particle tra-
versals through cells activates adaptive response radio-protection
against alpha particle chromosome damage and spontaneous cell
damage (see Figures 3 of Part II). Humans are exposed to low LET
radiations from natural background and man-made radiations. Using
the UNSCEAR (2000) estimate for these radiations given in Table 1
of Part II, it is shown in Tables A1, A2 and A3 of Part II, that sufficient
lung cell traversals can occur to induce an adaptive response reduc-
tion in human lung cancer risks. The very large range of the radia-
tions, world-wide, is sufficient to justify the very large variation in
lung cancer risks from the case-control studies by a very wide range
of AR protections.
4. A Papworth (1975) Poisson Validation Test for Linearity for the
Pooled Case-Control Data
In examining the case-control linear best fits in Figure 2 of Part I,
one can only conclude that either 1.) the Odds Ratio method of eval-
uating lung cancer risk is a very poor method of analysis or 2.) that
the above stated premise of “only carcinogenic sensitivity of the
human lung” is invalid. For this reason, in Section 3.2 we have
applied the Papworth Poisson Validation Test for Linearity
(Papworth 1975, Savage and Papworth 2000) to the pooled data with
the determination that the data does not reflect a single linear behav-
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ior and is over-dispersed when tested for a Poisson distribution about
a single linear function – thus reflecting other ancillary influences
causing the over-dispersion.
5. Adaptive Response Radio-Protection as the Only Plausible Ancillary
Influence
In Part I, we have shown that Bystander Damage should be the
dominant cause of radon progeny induced human lung cancers at
domestic and workplace radon levels. Without any external, ancillary
influences, the BEIR VI (1999) and pooled case-control data should
indeed reflect a single carcinogenic response, not linearly but fol-
lowing the shape of the bystander BaD Model illustrated in Figure 3
of Part I. Morgan (2006) and others have suggested that human
response to ionizing radiations should be non-linear and primarily
influenced by the Bystander Effect and Adaptive Response radio-pro-
tection. The only plausible influence that could cause such a very
large range, world-wide, of lung cancer risks from the case-control
studies must be AR protection. Adaptive response radio-protection is
noted in other dose response instances (Redpath and Mitchel 2006,
Redpath 2007, Redpath and Elmore 2007).
6. The Radiation Sources for the Activation of Adaptive Response
Protection in Lung Tissue
It is known that Poisson accumulated, low LET radiation induced,
single charged particle traversals through the cell nucleus activates
the adaptive response protective mechanisms. This is found to be
independent of the type low LET radiation from X-rays, gamma rays,
beta rays, electrons and even high energy protons. Thus all the low
LET natural background and man-made radiations, estimated in the
United Nations Table 1, will activate adaptive response protection.
The degree of protection simply depends on the fraction of lung cells
receiving charged particle traversals as tabulated in Tables A1, A2 and
A3 of the Appendix A of Part II. At the UNSCEAR (2000) world-wide
average human low LET exposures Table A3 and Figure 16 of Part II
estimates that a 40% reduction in lung cancer risks occurs at a radon
concentration of 400 Bq m-3. At the UNSCEAR (2000) Table 1 (of
Part II) minimum and maximum human natural background and
man-made radiation levels, it is estimated that 20% and 80% reduc-
tion occurs, respectively. Thus, as the pooled case-control studies
indicate, a very wide range of human lung cancer risks from radon
should be expected world-wide.
6.2 Summary of Part III
We have analyzed the data from the North American (Krewski et al
2005, 2006) pooled study, the European (Darby et al 2005, 2006) pooled
study, the Massachusetts (Thompson et al 2008) study and the China
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(Blot et al 1990). The North American study included 3662 lung cancer
cases and 4966 controls. The European study included 7148 cases and
14269 controls. Altogether our analysis encompassed over 11000 cases
and 20000 controls. By applying the Papworth (1975) Poisson Validation
Test for linear correlation it is shown that the basic premises of Krewski
et al (2005, 2006) and Darby et al (2005, 2006) that “between-site differ-
ences seen in the observed relationship between lung cancer risk and
radon exposure are due to random measurement variability and the true
relationship is independent of site locality and only dependent on the
carcinogenic sensitivity of human lung tissue to alpha radiation” in con-
clusively invalid. Case-control studies show zero and negative lung cancer
risks with increasing human radon exposure. By dividing the studies into
two groups. those showing positive risks (high groups) and those showing
zero or negative risks (low groups), polynomial fits were performed to the
data. The curves obtained for the high and low Darby et al (2005, 2006)
groups (Figures 4A and 4B) displayed non-coincidental, strong similarity
to the expected curves obtained from Figures 10 and 16 of Part I and
Figures 16, 17 and 18 of Part II. The Part II expected curves were derived
from the bystander BaD Model, reflecting primarily Bystander Damage as
the inductive damage for domestic and workplace radon lung cancers.
The polynomial fit for the Krewski et al (2005, 2006) high group matched
that for the Darby et al (2005, 2006) high group and the fit to the low
Krewski et al (2005, 2006) group showed no radon lung cancer risk and
a large reduction in the zero radon natural spontaneous risks. In Figure
7B, we estimate an adaptive response reduction of about 27% for the
Darby et al (2005, 2006) and Krewski et al (2005, 2006) high groups,
about a 72% AR reduction for the low Darby et al (2005, 2006) group and
a 100% AR reduction for the Krewski et al (2005, 2006) low group.
6. CONCLUSIONS
The human lung cancer risk from radon is not linear with increasing
radon concentration exposure for two primary reasons. First, the neo-
plastic transformation frequency and the chromosome aberration rates
of cellular damage from alpha particles originates from bystander effect
damage at normal domestic and workplace radon levels, which has a con-
cave response structure with increasing radon. At about 450 Bq m-3 con-
centration, the cellular damage behavior and lung cancer risk experi-
ences a district transition to a quasi-linear-quadratic response with a “U”
shaped behavior in this transition region. Second, lung cancer incidence
from radon is suppressed by adaptive response radio-protection by natu-
ral background and man-made low LET radiations routinely experienced
by humans. This adaptive response protection on a cell-by-cell basis, when
experienced in human cells from these whole body exposures, dominates
the potential carcinogenic risks from the radon progeny alpha particles.
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This results in a very large variation in population averaged human lung
cancer risks from radon as evidenced by the case-control studies. For
human exposures to radon up to about 400 Bq m-3 in Europe and North
American, and perhaps worldwide depending on geological and ecologi-
cal conditions, humans have about a 30% chance that there is no lung
cancer risk from radon and a 20% chance that the adaptive response pro-
tection produces a reduced lung cancer risk below the natural, non-
radon, spontaneous level. This protection must be afforded to humans
with respect to other carcinogens and diseases There is evidence that the
cellular sensitive volume for radon induction of lung cancer is the entire
cell region (nucleus and cytoplasm) for the basal and secretory cells.
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